Halma plc 10.9% potential upside indicated by Barclays

Broker Ratings

Halma plc with ticker (LON:HLMA) now has a potential upside of 10.9% according to Barclays.



Barclays set a target price of 3,220 GBX for the company, which when compared to the Halma plc share price of 2,869 GBX at opening today (12/01/2022) indicates a potential upside of 10.9%. Trading has ranged between 2,214 (52 week low) and 3,270 (52 week high) with an average of 662,053 shares exchanging hands daily. The market capitalisation at the time of writing is £10,907,212,342.

Halma plc is a United Kingdom-based life-saving technology company. The Company operates through four segments: Process Safety, Infrastructure Safety, Environmental & Analysis and Medical. The Process Safety segment offers products, such as specialized interlocks that control critical processes safely; instruments that detect flammable and hazardous gases; and explosion protection and corrosion monitoring systems. The Infrastructure Safety segment offers products, such as fire detection systems, specialist fire suppression systems, elevator safety systems and people and vehicle flow technologies. The Environmental & Analysis segment offers products, such as opto-electronic technology and sensors, flow gap measurement instruments and gas conditioning products, and solutions for environmental data recording, water quality testing and ultraviolet (UV) water treatment. The Medical segment offers products, such as critical fluidic components, laboratory devices and systems.



Share on:
Find more news, interviews, share price & company profile here for:

    Halma Plc CFO Steve Gunning to retire, Carole Cran appointed as CFO Designate

    Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.

    Halma plc achieves record H1 results, continued dividend growth

    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.

    Halma Plc acquires Lamidey Noury, enhancing minimally invasive surgical solutions

    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.

      Search

      Search